These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The cytochrome P450 epoxygenase pathway regulates the hepatic inflammatory response in fatty liver disease. Schuck RN; Zha W; Edin ML; Gruzdev A; Vendrov KC; Miller TM; Xu Z; Lih FB; DeGraff LM; Tomer KB; Jones HM; Makowski L; Huang L; Poloyac SM; Zeldin DC; Lee CR PLoS One; 2014; 9(10):e110162. PubMed ID: 25310404 [TBL] [Abstract][Full Text] [Related]
6. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function. Imig JD Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096 [TBL] [Abstract][Full Text] [Related]
7. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases. Xu X; Zhang XA; Wang DW Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627 [TBL] [Abstract][Full Text] [Related]
8. Acute mercury toxicity modulates cytochrome P450, soluble epoxide hydrolase and their associated arachidonic acid metabolites in C57Bl/6 mouse heart. Amara IE; Elshenawy OH; Abdelrady M; El-Kadi AO Toxicol Lett; 2014 Apr; 226(1):53-62. PubMed ID: 24472606 [TBL] [Abstract][Full Text] [Related]
9. Role of epoxyeicosatrienoic acids in cardiovascular diseases and cardiotoxicity of drugs. Zhang Y; Gao L; Yao B; Huang S; Zhang Y; Liu J; Liu Z; Wang X Life Sci; 2022 Dec; 310():121122. PubMed ID: 36309225 [TBL] [Abstract][Full Text] [Related]
10. Epoxyeicosatrienoic acid pathway in human health and diseases. Bellien J; Joannides R J Cardiovasc Pharmacol; 2013 Mar; 61(3):188-96. PubMed ID: 23011468 [TBL] [Abstract][Full Text] [Related]
11. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology. Sacerdoti D; Gatta A; McGiff JC Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496 [TBL] [Abstract][Full Text] [Related]
12. Increases in levels of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids (EETs and DHETs) in liver and heart in vivo by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and in hepatic EET:DHET ratios by cotreatment with TCDD and the soluble epoxide hydrolase inhibitor AUDA. Diani-Moore S; Ma Y; Gross SS; Rifkind AB Drug Metab Dispos; 2014 Feb; 42(2):294-300. PubMed ID: 24311719 [TBL] [Abstract][Full Text] [Related]
13. Aging, estrogen loss and epoxyeicosatrienoic acids (EETs). Lee AR; Pechenino AS; Dong H; Hammock BD; Knowlton AA PLoS One; 2013; 8(8):e70719. PubMed ID: 23967089 [TBL] [Abstract][Full Text] [Related]
18. Alteration of epoxyeicosatrienoic acids in the liver and kidney of cytochrome P450 4F2 transgenic mice. Zhang B; Lai G; Liu X; Zhao Y Mol Med Rep; 2016 Dec; 14(6):5739-5745. PubMed ID: 27878278 [TBL] [Abstract][Full Text] [Related]
19. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice. Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266 [TBL] [Abstract][Full Text] [Related]
20. Time-dependent expression pattern of cytochrome P450 epoxygenases and soluble epoxide hydrolase in normal human placenta. Cizkova K; Tauber Z Acta Histochem; 2018 Aug; 120(6):513-519. PubMed ID: 29908721 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]